NCT01317030|TerminatedResults
Study Stopped
Study was terminated due to a business decision to cancel the entire project.
Loading search results
Sponsor study identifier
observational
25
1 country
1
Study Start
February 2011
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2011
Actual (reported)Study Completion
April 2011
Actual (reported)to evaluate tears between habitual contact lens wearers and non contact lens wearers
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2011
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 2011
Date type not reportedThis date has not been verified as actual or estimated.
March 2011
Actual (reported)March 9, 2011
Actual (reported)March 17, 2011
Actual (reported)April 2011
Actual (reported)January 9, 2020
Actual (reported)Hyaluronan Levels
Tear samples collected using a Schirmer tear strip and analyzed for hyaluronan (HA) levels, a lubricant found throughout the body, including tears. Levels will be compared between the lens wearers and non-lens wearers.
7 days following lens insertion
Senofilcon A Lenses, using Sensitive Eyes Saline Solution and/or Biotrue Multipurpose Solution
Senofilcon A lenses will be rubbed and rinsed with Bausch + Lomb Sensitive Eyes Saline. The lenses will then be placed into Biotrue multi-purpose solution and soaked for at least 10 hours but no more than 24 hours prior to lens insertion into one eye.
Senofilcon A lenses will be rubbed and rinsed each side with Bausch + Lomb Sensitive Eyes Saline just prior to lens insertion into fellow eye.
Specific characteristics are that one group will be habitual contact lens wearers, and the other group will be non-contact lens wearers (not having worn contact lenses within the last 7 days prior to baseline visit)
Bausch & Lomb Incorporated
Rochester, New York, 14609, United States
Robert Steffen, OD, MS
Bausch & Lomb Incorporated
25 participants (actual enrollment reported by the registry).
First Submitted
March 9, 2011
First Posted
March 17, 2011
Study Start
February 2011
Date type not reportedThis date has not been verified as actual or estimated.
Optimization of Assessment and Grading for Lid Wiper Epitheliopathy
No intervention
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
March 2011
Actual (reported)Study Completion
April 2011
Actual (reported)Last Updated
January 9, 2020
Results First Posted
January 9, 2020
Record last verified: 2020-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: